source
stringlengths 2
222
| date
stringlengths 19
19
| url
stringlengths 22
853
⌀ | text
stringlengths 0
10k
⌀ | title
stringlengths 0
701
| context_id
stringlengths 1
9
| document_id
stringclasses 2
values | document_type
stringclasses 2
values |
|---|---|---|---|---|---|---|---|
Seeking Alpha | 2022-08-16 21:31:04 | https://seekingalpha.com/article/4535048-agilent-technologies-inc-ceo-mike-mcmullen-on-q3-2022-results-earnings-call-transcript | Agilent Technologies, Inc. (NYSE:A ) Q3 2022 Earnings Conference Call August 16, 2022 4:30 PM ET Company Participants Parmeet Ahuja - Investor Relations Mike McMullen - President and Chief Executive Officer Bob McMahon - Senior Vice President and Chief Financial Officer Jacob Thaysen - President, Agilent Life Science and Applied Markets Group Sam Raha - President, Agilent Diagnostics and Genomics Group Padraig McDonnell - President, Agilent CrossLab Group Conference Call Participants Matt Sykes - Goldman Sachs Brandon Couillard - Jefferies Vijay Kumar - Evercore ISI Puneet Souda - SVB Rachel Vatnsdal - JPMorgan Mike Ryskin - Bank of America Josh Waldman - Cleveland Research Jack Meehan - Nephron Research Elizabeth Garcia - UBS Patrick Donnelly - Citi Tim Daley - Wells Fargo Operator Good afternoon. Thank you for attending today's Agilent Technologies Q3 ‘22 Earnings Call. | Agilent Technologies, Inc. (A) CEO Mike McMullen on Q3 2022 Results - Earnings Call Transcript | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-08-16 18:48:07 | https://www.zacks.com/stock/news/1968859/agilent-technologies-a-q3-earnings-and-revenues-beat-estimates | Agilent (A) delivered earnings and revenue surprises of 11.67% and 4.85%, respectively, for the quarter ended July 2022. Do the numbers hold clues to what lies ahead for the stock? | Agilent Technologies (A) Q3 Earnings and Revenues Beat Estimates | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Market Watch | 2022-08-16 16:29:10 | https://www.marketwatch.com/story/agilent-stock-rallies-after-quarterly-beat-guidance-increase-for-company-2022-08-16 | Shares of Agilent Technologies Inc. A, -0.84% rose more than 5% in the extended session Tuesday after the maker of lab instruments and other components reported fiscal third-quarter results above Wall Street expectations and raised guidance for the year. Agilent said it earned $329 million, or $1.10 a share, in the quarter, compared with $264 million, or 86 cents a share, in the year-ago period. | Agilent stock rallies after quarterly beat, guidance increase for company | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-08-12 18:03:05 | https://www.zacks.com/stock/news/1967911/agilent-technologies-q3-preview-can-the-earnings-streak-continue | The company has been on a blazing-hot earnings streak, chaining together nine consecutive bottom-line beats. | Agilent Technologies Q3 Preview: Can the Earnings Streak Continue? | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2022-08-11 08:00:00 | https://seekingalpha.com/article/4532789-agilent-technologies-stock-turning-bullish-ahead-of-q3-earnings | Agilent is set to report its fiscal Q3 earnings on August 16th. Shares have been under pressure all year amid broader macro headwinds, despite continued growth and earnings momentum. | Agilent Technologies: Turning Bullish Ahead Of Q3 Earnings | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2022-07-19 11:00:00 | https://www.businesswire.com/news/home/20220719005507/en/Agilent-to-Announce-Third-Quarter-Fiscal-Year-2022-Financial-Results-August-16/ | SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced it will release financial results for the third quarter of fiscal year 2022 after the stock market closes on Tuesday, Aug. 16. The company will host a live webcast of its investor conference call in listen-only mode on the same day. Details for the webcast: Date: Tuesday, Aug. 16, 2022. Time: 1:30 p.m. Pacific time. Access: A link to join the webcast will be provided in the Upcoming Events section of Agile | Agilent to Announce Third-Quarter Fiscal Year 2022 Financial Results August 16 | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-06-30 10:58:32 | https://www.zacks.com/stock/news/1946209/earnings-growth-price-strength-make-agilent-technologies-a-a-stock-to-watch | Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List. | Earnings Growth & Price Strength Make Agilent Technologies (A) a Stock to Watch | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2022-06-27 00:03:10 | https://seekingalpha.com/article/4520442-agilent-stock-valuation-buy-territory | For investors who have been waiting to buy shares in Agilent, this is probably a good time to buy at least a starter position. For the last couple of years, Agilent had traded above what fundamentals justified, and now finally shares are priced to deliver very decent 8-9% returns. | Agilent Technologies Valuation Just Re-Entered 'Buy' Territory | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-06-23 13:08:29 | https://www.zacks.com/stock/news/1943031/agilent-a-down-5-5-since-last-earnings-report-can-it-rebound | Agilent (A) reported earnings 30 days ago. What's next for the stock? | Agilent (A) Down 5.5% Since Last Earnings Report: Can It Rebound? | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2022-06-21 10:28:05 | https://seekingalpha.com/article/4519482-agilent-technologies-inc-ceo-mike-mcmullen-presents-goldman-sachs-43rd-annual-global | Agilent Technologies, Inc. (NYSE:A ) Goldman Sachs 43rd Annual Global Healthcare Conference June 15, 2022 1:00 PM ET Company Participants Mike McMullen - Chief Executive Officer Bob McMahon - Chief Financial Officer Conference Call Participants Matt Sykes - Goldman Sachs Matt Sykes Okay. Great. Welcome, everybody. | Agilent Technologies, Inc. (A) CEO Mike McMullen Presents at Goldman Sachs 43rd Annual Global Healthcare Conference (Transcript) | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-06-08 16:33:04 | https://www.zacks.com/stock/news/1936407/agilent-a-to-provide-genomics-innovation-via-new-tie-ups | Agilent (A) collaborates with Amazon's AWS and NVIDIA to provide advanced analytical solutions in the genomics space. | Agilent (A) to Provide Genomics Innovation Via New Tie-Ups | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2022-06-01 16:30:00 | https://www.businesswire.com/news/home/20220601006206/en/Agilent-to-Participate-in-Goldman-Sachs-43rd-Annual-Global-Healthcare-Conference/ | SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the company will participate in the Goldman Sachs 43rd Annual Healthcare Conference on Wednesday, June 15, in Rancho Palos Verdes, California. President and CEO Mike McMullen and Chief Financial Officer Bob McMahon will represent the company in a fireside chat that begins at 10 a.m. PT/1 p.m. ET. A link to the live event will be available on Agilent's investor relations website and a replay will be provide | Agilent to Participate in Goldman Sachs 43rd Annual Global Healthcare Conference | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-05-31 16:34:04 | https://www.zacks.com/stock/news/1932010/agilent-a-to-attract-biopharma-customers-with-apc-tie-up | Agilent (A) collaborates with APC Ltd. to combine their technologies and develop unique workflows to cater to the needs of customers in the biopharmaceutical and pharmaceutical industry. | Agilent (A) to Attract Biopharma Customers With APC Tie-Up | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-05-31 11:18:38 | https://www.zacks.com/stock/news/1931760/here-s-why-agilent-technologies-a-is-a-strong-momentum-stock | The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage. | Here's Why Agilent Technologies (A) is a Strong Momentum Stock | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-05-31 10:33:03 | https://www.zacks.com/stock/news/1931699/earnings-growth-price-strength-make-agilent-technologies-a-a-stock-to-watch | The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage. | Earnings Growth & Price Strength Make Agilent Technologies (A) a Stock to Watch | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-05-27 09:03:06 | https://www.zacks.com/stock/news/1930183/5-etf-areas-to-gain-from-memorial-day-2022-after | Memorial Day Weekend is around the corner and will start the summer travel season. These ETF areas are likely to gain this year from the Memorial Day event. | 5 ETF Areas to Gain From Memorial Day 2022 & After | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-05-26 13:33:12 | https://www.zacks.com/stock/news/1929830/what-makes-agilent-a-a-new-buy-stock | Agilent (A) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. | What Makes Agilent (A) a New Buy Stock | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Pulse2 | 2022-05-25 18:05:46 | https://pulse2.com/agilent-a-stock-price-161-target-and-outperform-rating/ | The shares of Agilent (NYSE: A) have received a $161 price target from Baird. These are the details. | Agilent (A) Stock Price: $161 Target And Outperform Rating | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-05-25 16:03:18 | https://www.zacks.com/stock/news/1929300/agilent-a-q2-earnings-surpass-estimates-revenues-rise-y-y | Agilent's (A) results for the fiscal second quarter reflect strong momentum in the pharma and chemical & energy market. | Agilent (A) Q2 Earnings Surpass Estimates, Revenues Rise Y/Y | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Stockmarketcom | 2022-05-25 13:36:29 | https://stockmarket.com/featured/top-stocks-to-watch-right-now-3-tech-stocks-in-focus-2022-05-25 | Could these tech stocks be worth looking at as the tech sector attempts a recovery? | Top Stocks To Watch Right Now? 3 Tech Stocks In Focus | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
MarketBeat | 2022-05-25 11:41:09 | https://www.marketbeat.com/originals/agilent-technologies-is-bottoming-but-dont-buy-it-yet/?SNAPI | Agilent Technologies (NASDAQ: A) had a good quarter in FQ2, and calendar Q1, but there is one glaring problem with the report. The company's results are good, and the outlook is good, but it's all priced into the stock and stock is still trading at over 25X its earnings. | Agilent Technologies Is Bottoming But Don't Buy It Yet | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2022-05-24 21:37:07 | https://seekingalpha.com/article/4514243-agilent-technologies-inc-ceo-mike-mcmullen-on-q2-2022-results-earnings-call-transcript | Agilent Technologies Inc. (NYSE:A ) Q2 2022 Results Conference Call May 24, 2022 4:30 PM ET Company Participants Parmeet Ahuja - VP, IR Mike McMullen - President and CEO Bob McMahon - SVP and CFO Jacob Thaysen - President, Life Sciences and Applied Markets Group Sam Raha - President, Diagnostics and Genomics Group Padraig McDonnell - President, CrossLab Group Conference Call Participants Vijay Kumar - Evercore ISI Matt Sykes - Goldman Sachs Brandon Couillard - Jefferies Puneet Souda - SVB Securities Derik De Bruin - Bank of America Patrick Donnelly - Citi Rachel Vatnsdal - JP Morgan Josh Waldman - Cleveland Research Jack Meehan - Nephron Research Daniel Arias - Stifel Catherine Schulte - Baird Operator Good afternoon and thank you for attending today's Agilent Technologies Inc. Q2 2022 Earnings Conference Call. My name is Selena, and I will be your moderator. | Agilent Technologies Inc. (A) CEO Mike McMullen on Q2 2022 Results - Earnings Call Transcript | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-05-24 18:49:10 | https://www.zacks.com/stock/news/1928711/agilent-technologies-a-q2-earnings-beat-estimates | Agilent (A) delivered earnings and revenue surprises of 1.80% and 0.33%, respectively, for the quarter ended April 2022. Do the numbers hold clues to what lies ahead for the stock? | Agilent Technologies (A) Q2 Earnings Beat Estimates | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-05-20 12:47:25 | https://www.zacks.com/stock/news/1927285/what-s-in-the-cards-for-agilent-technologies-a-q2-earnings | Agilent Technologies' (A) fiscal second-quarter results are expected to reflect portfolio strength and momentum across all segments. | What's in the Cards for Agilent Technologies' (A) Q2 Earnings? | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-05-17 16:33:05 | https://www.zacks.com/stock/news/1925592/agilent-technologies-a-earnings-expected-to-grow-what-to-know-ahead-of-next-week-s-release | Agilent (A) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. | Agilent Technologies (A) Earnings Expected to Grow: What to Know Ahead of Next Week's Release | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
GuruFocus | 2022-05-05 17:04:05 | https://www.gurufocus.com/news/1704552/parnassus-comments-on-agilent | Agilent ( A , Financial) reduced the Fund's performance by -0.47%, as its shares delivered a negative total return of -17.0%. The company beat Wall Street's expectations and raised guidance, but the stock fell as secular growth companies trading at premium multiples de-rated relative to the market. | Parnassus Comments on Agilent | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2022-04-26 11:00:00 | https://www.businesswire.com/news/home/20220426005932/en/Agilent-to-Announce-Second-Quarter-Fiscal-Year-2022-Financial-Results-May-24/ | SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #Agilent--Agilent Technologies Inc. (NYSE: A) today announced that it will release financial results for the second quarter of fiscal year 2022 after the stock market closes on Tuesday, May 24. The company will host a live webcast of its investor conference call in listen-only mode on the same day. Details for the webcast: Date: Tuesday, May 24, 2022. Time: 1:30 p.m. Pacific time. Access: Links to the webcast will be provided in the Upcoming Events section of Agilent | Agilent to Announce Second-Quarter Fiscal Year 2022 Financial Results May 24 | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2022-04-15 12:28:06 | https://seekingalpha.com/article/4501655-agilent-strong-leader-great-opportunities | Agilent looks fundamentally undervalued after losing 30% since its ATH. The company delivers consistently solid financial results and is forecasted to further increase its profitability. | Agilent: A Strong Leader With Great Opportunities | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-04-12 16:33:03 | https://www.zacks.com/commentary/1898003/4-testing-equipment-stocks-to-escape-a-challenging-industry | Coronavirus--led disruptions are hurting the Zacks Electronics - Testing Equipment industry. However, industry participants like A, AME, FTV and CGNX are set to gain from 5G prospects. | 4 Testing Equipment Stocks to Escape a Challenging Industry | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-04-07 12:48:14 | https://www.zacks.com/stock/news/1894882/agilent-a-boosts-pd-l1-ihc-28-8-pharmdx-use-in-european-union | Agilent Technologies (A) boosts its presence in the companion diagnostics market by expanding the use of PD-L1 IHC 28-8 pharmDx assay for esophageal squamous cell carcinoma treatment in the EU. | Agilent (A) Boosts PD-L1 IHC 28-8 pharmDX Use in European Union | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2022-03-31 09:59:34 | https://seekingalpha.com/article/4498943-fiw-etf-water-more-essential-than-oil-data | The FIW ETF: Because Water Is More Essential Than Oil (Or Data) | The FIW ETF: Because Water Is More Essential Than Oil (Or Data) | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-03-22 10:32:10 | https://www.zacks.com/stock/news/1885463/new-to-investing-this-1-computer-and-technology-stock-could-be-the-perfect-starting-point | Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service. | New to Investing? This 1 Computer and Technology Stock Could Be the Perfect Starting Point | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
ETF Trends | 2022-03-15 12:32:46 | https://www.etftrends.com/etf-building-blocks-channel/with-energy-security-in-spotlight-aces-has-allure/ | Russia's ongoing war with Ukraine is among the reasons that oil prices are soaring this year. Those high prices and geopolitical tensions are reminders that, for many nations, energy security is an essential element in broader national security plans. | With Energy Security in Spotlight, ACES Has Allure | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-03-11 10:32:03 | https://www.zacks.com/stock/news/1880809/new-to-investing-this-1-computer-and-technology-stock-could-be-the-perfect-starting-point | The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage. | New to Investing? This 1 Computer and Technology Stock Could Be the Perfect Starting Point | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-02-24 11:35:49 | https://www.zacks.com/stock/news/1872615/down-5-6-in-4-weeks-here-s-why-agilent-a-looks-ripe-for-a-turnaround | Agilent (A) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term. | Down 5.6% in 4 Weeks, Here's Why Agilent (A) Looks Ripe for a Turnaround | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-02-23 12:20:09 | https://www.zacks.com/stock/news/1871891/agilent-a-q1-earnings-revenues-beat-estimates-rise-y-y | Agilent's (A) fiscal first-quarter results benefit from solid momentum across all operating segments. Further, strong growth in the pharma market remains a tailwind. | Agilent (A) Q1 Earnings & Revenues Beat Estimates, Rise Y/Y | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2022-02-22 21:24:02 | https://seekingalpha.com/article/4489224-agilent-technologies-inc-s-ceo-mike-mcmullen-on-q1-2022-results-earnings-call-transcript | Agilent Technologies, Inc.'s (A) CEO Mike McMullen on Q1 2022 Results - Earnings Call Transcript | Agilent Technologies, Inc.'s (A) CEO Mike McMullen on Q1 2022 Results - Earnings Call Transcript | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-02-22 18:28:09 | https://www.zacks.com/stock/news/1871406/agilent-technologies-a-q1-earnings-and-revenues-beat-estimates | Agilent (A) delivered earnings and revenue surprises of 3.42% and 1.30%, respectively, for the quarter ended January 2022. Do the numbers hold clues to what lies ahead for the stock? | Agilent Technologies (A) Q1 Earnings and Revenues Beat Estimates | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Benzinga | 2022-02-22 17:03:00 | https://www.benzinga.com/news/earnings/22/02/25767416/benzingas-after-hours-earnings-roundup-agilent-technologies-mosaic-palo-alto-networks-and-more | Benzinga's after-hours earnings roundup aims to deliver quick details about a company's earnings report, its forward-looking guidance and any other notable details. The list is handpicked by the reporters on the Benzinga Pro Newsdesk team. | Benzinga's After-Hours Earnings Roundup: Agilent Technologies, Mosaic, Palo Alto Networks And More | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-02-03 10:45:18 | https://www.zacks.com/stock/news/1862023/new-to-investing-this-1-computer-and-technology-stock-could-be-the-perfect-starting-point | The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage. | New to Investing? This 1 Computer and Technology Stock Could Be the Perfect Starting Point | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-01-04 18:25:05 | https://www.zacks.com/stock/news/1847342/test-for-feed-earnings-esp | Test for Feed Earnings ESP | Test for Feed Earnings ESP | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-01-04 18:25:04 | https://www.zacks.com/stock/news/1847344/test-for-feed-546-tale-of-the-tape-zacks-education-value-score | 546 Tale of the Tape : Zacks Education Value Score | Test for feed 546 Tale of the Tape : Zacks Education Value Score | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-01-04 18:25:03 | https://www.zacks.com/stock/news/1847345/test-feed-547-tale-of-the-tape-zacks-education-growth-score | 547 Tale of the Tape : Zacks Education Growth Score | Test Feed 547 Tale of the Tape : Zacks Education Growth Score | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2022-01-01 02:47:35 | https://seekingalpha.com/article/4477484-11-dividend-increases-to-start-2022-including-a-dividend-king | 11 Dividend Increases To Start 2022 Including A Dividend King | 11 Dividend Increases To Start 2022 Including A Dividend King | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-12-29 19:54:09 | https://www.zacks.com/stock/news/1845229/agilent-technologies-a-outpaces-stock-market-gains-what-you-should-know | Agilent Technologies (A) closed at $160.65 in the latest trading session, marking a +0.92% move from the prior day. | Agilent Technologies (A) Outpaces Stock Market Gains: What You Should Know | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-12-22 19:53:09 | https://www.zacks.com/stock/news/1842573/agilent-technologies-a-outpaces-stock-market-gains-what-you-should-know | Agilent Technologies (A) closed at $156.78 in the latest trading session, marking a +1.83% move from the prior day. | Agilent Technologies (A) Outpaces Stock Market Gains: What You Should Know | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-12-22 13:00:18 | https://www.zacks.com/stock/news/1842415/why-is-agilent-a-down-0-5-since-last-earnings-report | Agilent (A) reported earnings 30 days ago. What's next for the stock? | Why Is Agilent (A) Down 0.5% Since Last Earnings Report? | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2021-12-14 11:00:00 | https://www.businesswire.com/news/home/20211213006103/en/Agilent-to-Present-at-Goldman-Sachs-and-J.P.-Morgan-Healthcare-Conferences/ | SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #Agilent--Agilent Technologies Inc. (NYSE: A) today announced the company will deliver presentations at the Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference and the J.P. Morgan 40th Annual Healthcare Conference. Both conferences will be webcast. Details are included below. Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference Date: Jan. 6, 2022 Time: 11 a.m. ET/8 a.m. PT Presenting for Agilent: Mike McMullen, Agilent chief executive officer B | Agilent to Present at Goldman Sachs and J.P. Morgan Healthcare Conferences | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-12-10 13:03:12 | https://www.zacks.com/commentary/1837973/3-electronics-stocks-with-bright-industry-prospects-to-watch | The Zacks Electronics - Testing Equipment industry players, A, AME and TER, are poised well to benefit from 5G prospects and the ongoing work-from-home trend. | 3 Electronics Stocks With Bright Industry Prospects to Watch | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2021-12-02 20:56:18 | https://seekingalpha.com/article/4473120-dividend-champions-for-december-2021 | Monthly update of the Dividend Champions List. 75 companies declared higher dividends in the past month, with an average increase of 8.55% over their previous payouts. | Dividend Champions For December 2021 | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2021-11-23 15:00:00 | https://www.businesswire.com/news/home/20211123006093/en/Agilent-to-Present-at-Evercore-ISI-Virtual-Healthcare-Conference/ | SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #Agilent--Agilent to present at Evercore ISI Virtual Healthcare Conference. | Agilent to Present at Evercore ISI Virtual Healthcare Conference | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-11-23 14:34:05 | https://www.zacks.com/stock/news/1831053/agilent-s-a-q4-earnings-revenues-beat-estimates-rise-y-y | Agilent Technologies' (A) fourth-quarter fiscal 2021 results reflect a solid end-market momentum and strong growth across Americas and China. | Agilent's (A) Q4 Earnings & Revenues Beat Estimates, Rise Y/Y | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2021-11-22 23:54:04 | https://seekingalpha.com/article/4471346-agilent-technologies-inc-ceo-mike-mcmullen-on-q4-2021-results-earnings-call-transcript | Agilent Technologies, Inc. (A) CEO Mike McMullen on Q4 2021 Results - Earnings Call Transcript | Agilent Technologies, Inc. (A) CEO Mike McMullen on Q4 2021 Results - Earnings Call Transcript | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Benzinga | 2021-11-22 21:05:44 | https://www.benzinga.com/news/earnings/21/11/24237579/recap-agilent-technologies-q4-earnings | Agilent Technologies (NYSE:A) reported its Q4 earnings results on Monday, November 22, 2021 at 04:05 PM. Here's what investors need to know about the announcement. | Recap: Agilent Technologies Q4 Earnings | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-11-22 19:07:13 | https://www.zacks.com/stock/news/1830621/agilent-technologies-a-tops-q4-earnings-and-revenue-estimates | Agilent (A) delivered earnings and revenue surprises of 3.42% and 0.40%, respectively, for the quarter ended October 2021. Do the numbers hold clues to what lies ahead for the stock? | Agilent Technologies (A) Tops Q4 Earnings and Revenue Estimates | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2021-11-21 09:00:00 | https://seekingalpha.com/article/4471023-dividend-increases-november-13-19-2021 | This weekly article series covers dividend changes. A summary table presents relevant data and key statistics of dividend increases. | Dividend Increases: November 13-19, 2021 | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-11-18 10:43:13 | https://www.zacks.com/stock/news/1829315/agilent-a-to-report-q4-earnings-what-s-in-the-offing | Agilent's (A) fiscal fourth-quarter results are expected to reflect portfolio strength and momentum across all segments. | Agilent (A) to Report Q4 Earnings: What's in the Offing? | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
GuruFocus | 2021-11-16 16:31:33 | https://www.gurufocus.com/news/1575149/ackman-axes-agilent-technologies-in-3rd-quarter | Bill Ackman (Trades, Portfolio) has revealed his portfolio for the third quarter of 2021. The quarter saw Ackman sell out of his Agilent Technologies Inc. ( A , Financial) holding and make additions to his Chipotle Mexican Grill Inc. ( CMG , Financial), Domino's Pizza Inc. ( DPZ , Financial), Lowe's Companies Inc. ( LOW , Financial) and Hilton Worldwide Holdings Inc. ( HLT , Financial) positions. | Ackman Axes Agilent Technologies in 3rd Quarter | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
24/7 Wall Street | 2021-11-16 10:45:13 | https://247wallst.com/investing/2021/11/16/4-top-analyst-stock-picks-with-dividend-hikes-expected-this-week/ | After years of a low interest rate environment, many investors have turned to equities not only for the growth potential but also for solid and dependable dividends, which help to provide an income stream. | 4 Top Analyst Stock Picks With Dividend Hikes Expected This Week | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-11-16 10:00:24 | https://www.zacks.com/stock/news/1828233/why-earnings-season-could-be-great-for-agilent-a | Agilent (A) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season. | Why Earnings Season Could Be Great for Agilent (A) | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-11-15 16:11:08 | https://www.zacks.com/stock/news/1828030/agilent-technologies-a-reports-next-week-wall-street-expects-earnings-growth | Agilent (A) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. | Agilent Technologies (A) Reports Next Week: Wall Street Expects Earnings Growth | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2021-11-15 09:08:51 | https://seekingalpha.com/article/4469458-dividend-increases-from-merck-nike-and-12-others | Investors saw a few very good dividend increases in the first half of November, with ADP, Snap-on, and Roper Technologies announcing double-digit boosts, and a massive 29% boost from HP. The second half of November will bring double-digit boosts from a few more companies including Nike, Motorola Solutions, Aflac, and Agilent Technologies. | Second Half Of November Brings Dividend Increases From Merck, Nike And 12 Others | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-11-09 19:49:33 | https://www.zacks.com/stock/news/1826192/agilent-technologies-a-dips-more-than-broader-markets-what-you-should-know | Agilent Technologies (A) closed the most recent trading day at $159.81, moving -0.7% from the previous trading session. | Agilent Technologies (A) Dips More Than Broader Markets: What You Should Know | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-11-01 13:49:16 | https://www.zacks.com/stock/news/1820945/why-the-earnings-surprise-streak-could-continue-for-agilent-a | Agilent (A) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report. | Why the Earnings Surprise Streak Could Continue for Agilent (A) | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Forbes | 2021-10-31 15:35:32 | https://www.forbes.com/sites/greatspeculations/2021/10/31/stocks-this-week-buy-proshares-ultra-qqq-and-agilent-technologies/ | Here are trading recommendations for this coming strong week. | Stocks This Week: Buy ProShares Ultra QQQ And Agilent Technologies | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Benzinga | 2021-10-27 07:45:32 | https://www.benzinga.com/news/21/10/23630155/eclusive-agilent-commits-to-net-zero-greenhouse-gas-emissions-by-2050 | Agilent Technologies Inc (NYSE: A) has committed to achieving net-zero greenhouse gas emissions no later than 2050. Agilent has also committed to interim greenhouse gas reduction targets. | ECLUSIVE: Agilent Commits to Net-Zero Greenhouse Gas Emissions By 2050 | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-10-20 11:40:29 | https://www.zacks.com/stock/news/1813249/etfs-to-ride-on-a-solid-start-to-q3-earnings | The rounds of upbeat earnings has set the stage for the S&P 500 Index to hit new highs as more Q3 earnings unfold. | ETFs to Ride on a Solid Start to Q3 Earnings | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2021-10-13 16:16:00 | https://www.businesswire.com/news/home/20211013006127/en/Agilent-Receives-FDA-Companion-Diagnostic-Approval-for-Ki-67-IHC-MIB-1-pharmDx-in-High-Risk-Early-Breast-Cancer/ | SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced its Ki-67 IHC MIB-1 pharmDx (Dako Omnis) is now FDA approved as an aid in identifying patients with early breast cancer (EBC) at high risk of disease recurrence, for whom adjuvant treatment with Verzenio® (abemaciclib) in combination with endocrine therapy is being considered. This is the first IHC assay measuring Ki-67 expression to receive FDA approval in the context of treatment with Verzenio and was de | Agilent Receives FDA Companion Diagnostic Approval for Ki-67 IHC MIB-1 pharmDx in High-Risk Early Breast Cancer | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2021-09-26 02:57:36 | https://seekingalpha.com/article/4457099-dividend-champion-and-contender-highlights-week-of-september-26 | A weekly summary of dividend activity for Dividend Champions and Contenders. | Dividend Champion And Contender Highlights: Week Of September 26 | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2021-09-23 16:05:00 | https://www.businesswire.com/news/home/20210923005875/en/Dr.-Mikael-Dolsten-Named-to-Agilent-Board-of-Directors/ | SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #Agilent--Pfizer executive Dr. Mikael Dolsten appointed to Agilent board of directors. | Dr. Mikael Dolsten Named to Agilent Board of Directors | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-09-17 10:42:07 | https://www.zacks.com/stock/news/1797777/new-to-investing-this-1-computer-and-technology-stock-could-be-the-perfect-starting-point | Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service. | New to Investing? This 1 Computer and Technology Stock Could Be the Perfect Starting Point | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-09-03 13:45:07 | https://www.zacks.com/stock/news/1791821/agilent-a-visiopharm-unite-for-supply-of-pathology-solutions | Agilent (A) signs an agreement with Visiopharm to globally distribute their pathology solutions. | Agilent (A), Visiopharm Unite for Supply of Pathology Solutions | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-09-03 13:00:21 | https://www.zacks.com/stock/news/1791161/has-agilent-technologies-a-outpaced-other-computer-and-technology-stocks-this-year | Is (A) Outperforming Other Computer and Technology Stocks This Year? | Has Agilent Technologies (A) Outpaced Other Computer and Technology Stocks This Year? | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
GuruFocus | 2021-09-03 12:30:15 | https://www.gurufocus.com/news/1516374/3-stocks-growing-free-cash-flow-fast | If you are screening the market for investment opportunities among U.S.-listed equities, you may want to consider the stocks listed below, as they have seen their free cash flow (FCF) grow notably over recent years. As a result, these businesses should be flexible enough to continue to support the development of projects and return cash to shareholders. | 3 Stocks Growing Free Cash Flow Fast | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2021-09-01 11:00:00 | https://www.businesswire.com/news/home/20210901005166/en/Agilent-to-Present-at-Wells-Fargo-Virtual-Healthcare-Conference/ | SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #Agilent--Agilent to present at 2021 Wells Fargo Virtual Healthcare Conference. | Agilent to Present at Wells Fargo Virtual Healthcare Conference | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-09-01 10:45:12 | https://www.zacks.com/stock/news/1789660/agilent-technologies-a-boasts-earnings-price-momentum-should-you-buy | Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service. | Agilent Technologies (A) Boasts Earnings & Price Momentum: Should You Buy? | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Reuters | 2021-08-24 18:30:00 | https://www.reuters.com/business/finance/ackman-committed-finding-deal-psth-sold-agilent-raise-cash-2021-08-24/ | Billionaire investor William Ackman, who last year launched the biggest-ever special-purpose acquisition company, said on Tuesday he remains committed to finding a merger partner for his blank-check company Pershing Square Tontine Holdings Ltd (PSTH). | Ackman committed to finding a deal for PSTH; sold Agilent to raise cash | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
24/7 Wall Street | 2021-08-24 07:35:45 | https://247wallst.com/investing/2021/08/24/goldman-sachs-boosts-price-targets-on-4-strong-buy-rated-stocks/ | With August almost over and the back-to-school season upon us, the lion's share of the outstanding second-quarter earnings results have been posted, and analysts and investors on Wall Street are very satisfied with the results. | Goldman Sachs Boosts Price Targets on 4 Strong Buy-Rated Stocks | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2021-08-23 11:00:00 | https://www.businesswire.com/news/home/20210823005355/en/Agilent-Companion-Diagnostic-Expands-CE-IVD-Mark-in-Europe-to-Include-Esophageal-Cancer/ | SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that the company's PD-L1 IHC 22C3 pharmDx assay has expanded its use in Europe. The assay is now CE-IVD marked for use as an aid in identifying esophageal cancer patients for treatment with KEYTRUDA using Combined Positive Score (CPS) ≥ 10.1 In Europe, KEYTRUDA is approved in combination with platinum- and fluoropyrimidine-based chemotherapy for patients with locally advanced unresectable or metastatic eso | Agilent Companion Diagnostic Expands CE-IVD Mark in Europe to Include Esophageal Cancer | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2021-08-22 01:50:16 | https://seekingalpha.com/article/4451093-agilent-technologies-momentum-genomics-keeps-it-interesting | Agilent Technologies: Momentum In Genomics Keeps It Interesting | Agilent Technologies: Momentum In Genomics Keeps It Interesting | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
CNBC Television | 2021-08-18 20:00:59 | https://www.youtube.com/watch?v=kD4YHzj7YYg | Agilent CEO Mike McMullen told CNBC's Jim Cramer on Wednesday he's confident in the life sciences company's core business growth. | Agilent CEO confident on the growth of the company's non-Covid business | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-08-18 12:15:16 | https://www.zacks.com/stock/news/1783353/agilent-a-q3-earnings-revenues-beat-estimates-rise-y-y | Agilent's (A) fiscal third-quarter results benefit from strength across all geographical regions, business groups and end-market momentum. | Agilent (A) Q3 Earnings & Revenues Beat Estimates, Rise Y/Y | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Benzinga | 2021-08-18 11:01:03 | https://www.benzinga.com/news/earnings/21/08/22558079/agilent-stock-trading-at-52-week-high-as-analysts-beef-up-target-price-after-q3-earnings | Agilent Technologies Inc (NYSE: A) reported third-quarter revenue of $1.59 billion, +26% and up 21% on a core basis, slightly beating the consensus of $1.54 billion. During the third quarter, revenues for the diagnostic and genomics group (DGG) rose 44% to $346 million. | Agilent Stock Trading At 52-Week High As Analysts Beef Up Target Price After Q3 Earnings | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2021-08-17 20:08:14 | https://seekingalpha.com/article/4450247-agilent-technologies-inc-ceo-mike-mcmullen-on-q3-2021-results-earnings-call-transcript | Agilent Technologies, Inc. (A) CEO Mike McMullen on Q3 2021 Results - Earnings Call Transcript | Agilent Technologies, Inc. (A) CEO Mike McMullen on Q3 2021 Results - Earnings Call Transcript | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-08-17 19:00:15 | https://www.zacks.com/stock/news/1782990/agilent-technologies-a-q3-earnings-and-revenues-surpass-estimates | Agilent (A) delivered earnings and revenue surprises of 11.11% and 3.67%, respectively, for the quarter ended July 2021. Do the numbers hold clues to what lies ahead for the stock? | Agilent Technologies (A) Q3 Earnings and Revenues Surpass Estimates | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Benzinga | 2021-08-17 16:37:30 | https://www.benzinga.com/news/earnings/21/08/22545410/recap-agilent-technologies-q3-earnings | Shares of Agilent Technologies (NYSE:A) fell 0.6% in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share were up 41.03% year over year to $1.10, which beat the estimate of $0.99. | Recap: Agilent Technologies Q3 Earnings | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2021-08-17 16:05:00 | https://www.businesswire.com/news/home/20210817005814/en/Agilent-Reports-Third-Quarter-Fiscal-Year-2021-Financial-Results/ | SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #Agilent--Agilent reports strong fiscal third quarter financial results, raises full-year guidance. | Agilent Reports Third-Quarter Fiscal Year 2021 Financial Results | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-08-16 11:26:16 | https://www.zacks.com/stock/news/1782253/agilent-a-to-report-q3-earnings-what-s-in-the-cards | Agilent's (A) fiscal third-quarter results are likely to reflect strength across its segments and product portfolio. | Agilent (A) to Report Q3 Earnings: What's in the Cards? | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-08-10 16:17:09 | https://www.zacks.com/stock/news/1777785/agilent-technologies-a-earnings-expected-to-grow-what-to-know-ahead-of-next-week-s-release | Agilent (A) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. | Agilent Technologies (A) Earnings Expected to Grow: What to Know Ahead of Next Week's Release | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-08-06 06:54:19 | https://www.zacks.com/stock/news/1775835/5-corporate-giants-to-buy-ahead-of-earnings-results-this-month | Five corporate bigwigs are slated to release their earnings results this month. These are: WMT, A, TGT, DE and ULTA. | 5 Corporate Giants to Buy Ahead of Earnings Results This Month | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2021-08-04 11:00:00 | https://www.businesswire.com/news/home/20210804005219/en/Agilent-Earns-2021-Great-Place-to-Work-Certification-in-the-U.S./ | SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #Agilent--Agilent earns 2021 Great Place to Work certification in the U.S. | Agilent Earns 2021 Great Place to Work Certification in the U.S. | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2021-08-03 08:20:00 | https://www.businesswire.com/news/home/20210803005647/en/Agilent-Announces-Target-Enrichment-Manufacturing-Facility-in-China/ | SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that is has established in-country manufacturing for its SureSelect portfolio at its facility in Hangzhou, China. Agilent is a leading provider of next-generation sequencing assays, and customers often develop custom panels for their routine applications. Therefore, delivery turnaround time is an essential aspect of how Agilent uniquely serves its customers, enabling them to validate and implement their as | Agilent Announces Target Enrichment Manufacturing Facility in China | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-08-02 13:43:36 | https://www.zacks.com/stock/news/1772679/are-you-looking-for-a-top-momentum-pick-why-agilent-technologies-a-is-a-great-choice | Does Agilent Technologies (A) have what it takes to be a top stock pick for momentum investors? Let's find out. | Are You Looking for a Top Momentum Pick? Why Agilent Technologies (A) is a Great Choice | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-08-02 13:43:24 | https://www.zacks.com/stock/news/1772677/can-agilent-a-keep-the-earnings-surprise-streak-alive | Agilent (A) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report. | Can Agilent (A) Keep the Earnings Surprise Streak Alive? | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-07-30 12:55:21 | https://www.zacks.com/commentary/1771734/3-stocks-with-price-and-earnings-estimate-momentum | 3 Stocks With Price and Earnings Estimate Momentum | 3 Stocks With Price and Earnings Estimate Momentum | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2021-07-22 11:00:00 | https://www.businesswire.com/news/home/20210722005127/en/Agilent-Technologies-Celebrates-More-than-20-Years-of-Sustainable-Progress/ | SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #Agilent--Agilent issues 2020 corporate social responsibility report. | Agilent Technologies Celebrates More than 20 Years of Sustainable Progress | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-07-21 12:23:13 | https://www.zacks.com/stock/news/1765058/agilent-a-expands-pharmdx-assay-use-in-the-european-union | Agilent Technologies (A) expands the use of PD-L1 IHC 22C3 pharmDx assay for cancer treatment in the European Union. | Agilent (A) Expands pharmDX Assay Use in the European Union | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2021-07-20 12:34:00 | https://www.businesswire.com/news/home/20210720006000/en/Agilent-PD-L1-IHC-22C3-pharmDx-Expands-CE-IVD-mark-in-Non-small-Cell-Lung-Cancer-NSCLC/ | SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that the company's PD-L1 IHC 22C3 pharmDx assay is now labeled for expanded use in patients with non-small cell lung cancer (NSCLC) in the European Union. PD-L1 IHC 22C3 pharmDx can now be used as an aid in identifying NSCLC patients with tumor PD-L1 expression of Tumor Proportion Score (TPS) ≥ 50% for treatment with Libtayo® (cemiplimab). This announcement underscores Agilent's continuing commitment to th | Agilent PD-L1 IHC 22C3 pharmDx Expands CE-IVD mark in Non-small Cell Lung Cancer (NSCLC) | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-07-05 12:47:14 | https://www.zacks.com/stock/news/1757714/what-makes-agilent-technologies-a-a-strong-momentum-stock-buy-now | Does Agilent Technologies (A) have what it takes to be a top stock pick for momentum investors? Let's find out. | What Makes Agilent Technologies (A) a Strong Momentum Stock: Buy Now? | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-07-05 11:16:06 | https://www.zacks.com/stock/news/1757632/agilent-technologies-a-boasts-earnings-price-momentum-should-you-buy | Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service. | Agilent Technologies (A) Boasts Earnings & Price Momentum: Should You Buy? | A | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |